+Follow
Desmondsg
No personal profile
3
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
Desmondsg
07-12
$SoundHound AI Inc(SOUN)$
Desmondsg
06-10
Share your opinion about this news…
Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds
Desmondsg
03-20
$Ley Choon(Q0X.SI)$
Desmondsg
03-12
Share your opinion about this news…
US February Core Inflation Data Slightly Hotter Than Expected
Desmondsg
02-13
$PanUnited(P52.SI)$
Desmondsg
02-02
$CapLand Ascott T(HMN.SI)$
Desmondsg
01-16
$Alset International Ltd(40V.SI)$
Desmondsg
01-15
$CapLand Ascott T(HMN.SI)$
Desmondsg
2023-08-21
$Alset International Ltd(40V.SI)$
Desmondsg
2023-08-03
$YZJ Fin Hldg(YF8.SI)$
Desmondsg
2023-08-02
$SINGAPORE AIRLINES LTD(C6L.SI)$
Desmondsg
2023-02-23
$ACESIAN PARTNERS LIMITED(5FW.SI)$
Desmondsg
2023-02-10
$CIVMEC LIMITED(P9D.SI)$
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":3557888867112544,"uuid":"3557888867112544","gmtCreate":1596628006302,"gmtModify":1596628006302,"name":"Desmondsg","pinyin":"desmondsg","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.04","exceedPercentage":"93.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":7,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":326722133528704,"gmtCreate":1720799510622,"gmtModify":1720799513422,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOUN\">$SoundHound AI Inc(SOUN)$</a> ","listText":"<a href=\"https://ttm.financial/S/SOUN\">$SoundHound AI Inc(SOUN)$</a> ","text":"$SoundHound AI Inc(SOUN)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/326722133528704","isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":315366116900928,"gmtCreate":1718025058016,"gmtModify":1718025061574,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/315366116900928","repostId":"2442810348","repostType":2,"repost":{"id":"2442810348","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1718032850,"share":"https://ttm.financial/m/news/2442810348?lang=&edition=fundamental","pubTime":"2024-06-10 23:20","market":"sh","language":"en","title":"Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds","url":"https://stock-news.laohu8.com/highlight/detail?id=2442810348","media":"Dow Jones","summary":"$Moderna, Inc.(MRNA)$'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company re","content":"<html><head></head><body><p>Novavax drops 10% after <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/75782cd701ec40d90497b85d14595a6b\" tg-width=\"450\" tg-height=\"392\"/></p><p>The late-stage trial compared the investigational combo shot mRNA-1083 against the <a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a> flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against <a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline PLC</a> 's Fluarix flu vaccine and Spikevax.</p><p>In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.</p><p>Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.</p><p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> last month announced a deal that includes development of new flu and COVID combination vaccines.</p><p>"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses," Moderna CEO Stephane Bancel said in a statement.</p><p>In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is "just easier to administer - one shot and you're done," Moderna Chief Financial Officer Jamey Mock told MarketWatch. "And hopefully it reduces the overall cost for them, because it should save time."</p><p>The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. "Clearly, we were able to do that," Mock said.</p><p>The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. "We don't see that" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.</p><p>Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.</p><p>It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-06-10 23:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Novavax drops 10% after <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/75782cd701ec40d90497b85d14595a6b\" tg-width=\"450\" tg-height=\"392\"/></p><p>The late-stage trial compared the investigational combo shot mRNA-1083 against the <a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a> flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against <a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline PLC</a> 's Fluarix flu vaccine and Spikevax.</p><p>In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.</p><p>Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.</p><p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> last month announced a deal that includes development of new flu and COVID combination vaccines.</p><p>"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses," Moderna CEO Stephane Bancel said in a statement.</p><p>In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is "just easier to administer - one shot and you're done," Moderna Chief Financial Officer Jamey Mock told MarketWatch. "And hopefully it reduces the overall cost for them, because it should save time."</p><p>The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. "Clearly, we were able to do that," Mock said.</p><p>The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. "We don't see that" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.</p><p>Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.</p><p>It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU1829250122.USD":"高盛欧洲核心股票组合Acc","BNTX":"BioNTech SE","SG9999001176.USD":"United Global Healthcare Acc USD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK4532":"文艺复兴科技持仓","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY \"A\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4592":"伊斯兰概念","NVAX":"诺瓦瓦克斯医药","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4548":"巴美列捷福持仓","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4007":"制药","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","MRNA":"Moderna, Inc.","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4535":"淡马锡持仓","SG9999002232.USD":"Allianz Global High Payout USD","LU0058720904.USD":"联博国际健康护理基金A","BK4501":"段永平概念","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4568":"美国抗疫概念","BK4588":"碎股","BK4550":"红杉资本持仓","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","GSK":"葛兰素史克","BK4551":"寇图资本持仓","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4547":"WSB热门概念","PFE":"辉瑞","LU0122379950.USD":"贝莱德世界健康科学A2","BK4581":"高盛持仓","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2442810348","content_text":"Novavax drops 10% after Moderna, Inc.'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.The late-stage trial compared the investigational combo shot mRNA-1083 against the Sanofi SA flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against GlaxoSmithKline PLC 's Fluarix flu vaccine and Spikevax.In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.Pfizer and BioNTech SE are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and Novavax last month announced a deal that includes development of new flu and COVID combination vaccines.\"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses,\" Moderna CEO Stephane Bancel said in a statement.In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is \"just easier to administer - one shot and you're done,\" Moderna Chief Financial Officer Jamey Mock told MarketWatch. \"And hopefully it reduces the overall cost for them, because it should save time.\"The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. \"Clearly, we were able to do that,\" Mock said.The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. \"We don't see that\" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":286273579040928,"gmtCreate":1710925827030,"gmtModify":1710925830427,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/Q0X.SI\">$Ley Choon(Q0X.SI)$</a> ","listText":"<a href=\"https://ttm.financial/S/Q0X.SI\">$Ley Choon(Q0X.SI)$</a> ","text":"$Ley Choon(Q0X.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/286273579040928","isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":283476442464392,"gmtCreate":1710246983863,"gmtModify":1710246997097,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/283476442464392","repostId":"1168053302","repostType":2,"repost":{"id":"1168053302","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1710246644,"share":"https://ttm.financial/m/news/1168053302?lang=&edition=fundamental","pubTime":"2024-03-12 20:30","market":"us","language":"en","title":"US February Core Inflation Data Slightly Hotter Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=1168053302","media":"Tiger Newspress","summary":"US CPI YoY Actual 3.2% (Forecast 3.1%, Previous 3.1%)","content":"<html><head></head><body><p>Inflation rose again in February, keeping the Federal Reserve on course to wait at least until the summer before starting to lower interest rates.</p><p style=\"text-align: start;\">The consumer price index, a broad measure of goods and services costs, increased 0.4% for the month and 3.2% from a year ago, the Labor Department’s Bureau of Labor Statistics reported Tuesday. The monthly gain was in line with expectations, but the annual rate was slightly ahead of the 3.1% forecast from the Dow Jones consensus.</p><p style=\"text-align: start;\">Excluding volatile food and energy prices, core CPI increased 0.4% on the month and was up 3.8% on the year. Both were one-tenth of a percentage point higher than forecast.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5889035925b31691d094d1900524c4b4\" title=\"\" tg-width=\"914\" tg-height=\"105\"/></p><p style=\"text-align: start;\">While the 12-month pace is off the inflation peak in mid-2022, it remains well above the Fed’s 2% goal as the central bank approaches its two-day policy meeting in a week.</p><p>A 2.3% increase in energy costs helped boost the headline inflation number. Food costs were flat on the month, while shelter rose another 0.4%.</p><p style=\"text-align: start;\">The BLS reported that the increases in energy and shelter amounted to more than 60% of the total gain.</p><p style=\"text-align: start;\">Markets showed little initial reaction after the news broke, with futures tied to major stock averages as well as Treasury yields slightly higher.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US February Core Inflation Data Slightly Hotter Than Expected</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS February Core Inflation Data Slightly Hotter Than Expected\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2024-03-12 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Inflation rose again in February, keeping the Federal Reserve on course to wait at least until the summer before starting to lower interest rates.</p><p style=\"text-align: start;\">The consumer price index, a broad measure of goods and services costs, increased 0.4% for the month and 3.2% from a year ago, the Labor Department’s Bureau of Labor Statistics reported Tuesday. The monthly gain was in line with expectations, but the annual rate was slightly ahead of the 3.1% forecast from the Dow Jones consensus.</p><p style=\"text-align: start;\">Excluding volatile food and energy prices, core CPI increased 0.4% on the month and was up 3.8% on the year. Both were one-tenth of a percentage point higher than forecast.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/5889035925b31691d094d1900524c4b4\" title=\"\" tg-width=\"914\" tg-height=\"105\"/></p><p style=\"text-align: start;\">While the 12-month pace is off the inflation peak in mid-2022, it remains well above the Fed’s 2% goal as the central bank approaches its two-day policy meeting in a week.</p><p>A 2.3% increase in energy costs helped boost the headline inflation number. Food costs were flat on the month, while shelter rose another 0.4%.</p><p style=\"text-align: start;\">The BLS reported that the increases in energy and shelter amounted to more than 60% of the total gain.</p><p style=\"text-align: start;\">Markets showed little initial reaction after the news broke, with futures tied to major stock averages as well as Treasury yields slightly higher.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168053302","content_text":"Inflation rose again in February, keeping the Federal Reserve on course to wait at least until the summer before starting to lower interest rates.The consumer price index, a broad measure of goods and services costs, increased 0.4% for the month and 3.2% from a year ago, the Labor Department’s Bureau of Labor Statistics reported Tuesday. The monthly gain was in line with expectations, but the annual rate was slightly ahead of the 3.1% forecast from the Dow Jones consensus.Excluding volatile food and energy prices, core CPI increased 0.4% on the month and was up 3.8% on the year. Both were one-tenth of a percentage point higher than forecast.While the 12-month pace is off the inflation peak in mid-2022, it remains well above the Fed’s 2% goal as the central bank approaches its two-day policy meeting in a week.A 2.3% increase in energy costs helped boost the headline inflation number. Food costs were flat on the month, while shelter rose another 0.4%.The BLS reported that the increases in energy and shelter amounted to more than 60% of the total gain.Markets showed little initial reaction after the news broke, with futures tied to major stock averages as well as Treasury yields slightly higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":273607305072704,"gmtCreate":1707836589600,"gmtModify":1707836594637,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P52.SI\">$PanUnited(P52.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/P52.SI\">$PanUnited(P52.SI)$ </a>","text":"$PanUnited(P52.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/273607305072704","isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":269740220919984,"gmtCreate":1706863495868,"gmtModify":1706863499641,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","text":"$CapLand Ascott T(HMN.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/269740220919984","isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":263701046235320,"gmtCreate":1705415979945,"gmtModify":1705415983384,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","text":"$Alset International Ltd(40V.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263701046235320","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":263229678129152,"gmtCreate":1705299217413,"gmtModify":1705299220322,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","text":"$CapLand Ascott T(HMN.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263229678129152","isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":211227475693680,"gmtCreate":1692594088904,"gmtModify":1692594091145,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","text":"$Alset International Ltd(40V.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/211227475693680","isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":204936082325656,"gmtCreate":1691042760903,"gmtModify":1691044335811,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$ </a>","text":"$YZJ Fin Hldg(YF8.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/204936082325656","isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":204411768676376,"gmtCreate":1690938436624,"gmtModify":1690940456811,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$ </a>","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/204411768676376","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957801933,"gmtCreate":1677130005623,"gmtModify":1677132258130,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/5FW.SI\">$ACESIAN PARTNERS LIMITED(5FW.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/5FW.SI\">$ACESIAN PARTNERS LIMITED(5FW.SI)$ </a>","text":"$ACESIAN PARTNERS LIMITED(5FW.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957801933","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954343201,"gmtCreate":1676031385804,"gmtModify":1676033889299,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P9D.SI\">$CIVMEC LIMITED(P9D.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/P9D.SI\">$CIVMEC LIMITED(P9D.SI)$ </a>","text":"$CIVMEC LIMITED(P9D.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9954343201","isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":204411768676376,"gmtCreate":1690938436624,"gmtModify":1690940456811,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$ </a>","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/204411768676376","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":283476442464392,"gmtCreate":1710246983863,"gmtModify":1710246997097,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/283476442464392","repostId":"1168053302","repostType":2,"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":315366116900928,"gmtCreate":1718025058016,"gmtModify":1718025061574,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/315366116900928","repostId":"2442810348","repostType":2,"repost":{"id":"2442810348","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1718032850,"share":"https://ttm.financial/m/news/2442810348?lang=&edition=fundamental","pubTime":"2024-06-10 23:20","market":"sh","language":"en","title":"Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds","url":"https://stock-news.laohu8.com/highlight/detail?id=2442810348","media":"Dow Jones","summary":"$Moderna, Inc.(MRNA)$'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company re","content":"<html><head></head><body><p>Novavax drops 10% after <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/75782cd701ec40d90497b85d14595a6b\" tg-width=\"450\" tg-height=\"392\"/></p><p>The late-stage trial compared the investigational combo shot mRNA-1083 against the <a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a> flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against <a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline PLC</a> 's Fluarix flu vaccine and Spikevax.</p><p>In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.</p><p>Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.</p><p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> last month announced a deal that includes development of new flu and COVID combination vaccines.</p><p>"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses," Moderna CEO Stephane Bancel said in a statement.</p><p>In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is "just easier to administer - one shot and you're done," Moderna Chief Financial Officer Jamey Mock told MarketWatch. "And hopefully it reduces the overall cost for them, because it should save time."</p><p>The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. "Clearly, we were able to do that," Mock said.</p><p>The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. "We don't see that" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.</p><p>Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.</p><p>It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna's Combo COVID and Flu Vaccine Works Better Than Stand-Alone Shots on the Market, Study Finds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-06-10 23:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Novavax drops 10% after <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.</p><p></p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/75782cd701ec40d90497b85d14595a6b\" tg-width=\"450\" tg-height=\"392\"/></p><p>The late-stage trial compared the investigational combo shot mRNA-1083 against the <a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a> flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against <a href=\"https://laohu8.com/S/GSK\">GlaxoSmithKline PLC</a> 's Fluarix flu vaccine and Spikevax.</p><p>In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.</p><p>Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.</p><p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> last month announced a deal that includes development of new flu and COVID combination vaccines.</p><p>"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses," Moderna CEO Stephane Bancel said in a statement.</p><p>In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is "just easier to administer - one shot and you're done," Moderna Chief Financial Officer Jamey Mock told MarketWatch. "And hopefully it reduces the overall cost for them, because it should save time."</p><p>The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. "Clearly, we were able to do that," Mock said.</p><p>The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. "We don't see that" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.</p><p>Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.</p><p>It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU1829250122.USD":"高盛欧洲核心股票组合Acc","BNTX":"BioNTech SE","SG9999001176.USD":"United Global Healthcare Acc USD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK4532":"文艺复兴科技持仓","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY \"A\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4592":"伊斯兰概念","NVAX":"诺瓦瓦克斯医药","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4548":"巴美列捷福持仓","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4007":"制药","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","MRNA":"Moderna, Inc.","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4535":"淡马锡持仓","SG9999002232.USD":"Allianz Global High Payout USD","LU0058720904.USD":"联博国际健康护理基金A","BK4501":"段永平概念","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4568":"美国抗疫概念","BK4588":"碎股","BK4550":"红杉资本持仓","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","GSK":"葛兰素史克","BK4551":"寇图资本持仓","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4547":"WSB热门概念","PFE":"辉瑞","LU0122379950.USD":"贝莱德世界健康科学A2","BK4581":"高盛持仓","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2442810348","content_text":"Novavax drops 10% after Moderna, Inc.'s experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company released Monday.The late-stage trial compared the investigational combo shot mRNA-1083 against the Sanofi SA flu vaccine Fluzone HD and Moderna's Spikevax COVID vaccine in adults 65 and older. For patients age 50 to 64, the trial compared the combination vaccine against GlaxoSmithKline PLC 's Fluarix flu vaccine and Spikevax.In both age groups, the two-in-one shot prompted higher immune responses against three flu strains as well as COVID, Moderna said.Analysts and pharmaceutical companies are looking to combination shots to help improve vaccine uptake and expand the respiratory-vaccine market. Looking at the most recent vaccination season, nearly half of U.S. adults were vaccinated against the flu as of early June, but less than a quarter were vaccinated against COVID, according to the Centers for Disease Control and Prevention.Pfizer and BioNTech SE are also working on a combined COVID and flu vaccine that is currently in Phase 3 trials, and Sanofi and Novavax last month announced a deal that includes development of new flu and COVID combination vaccines.\"Combination vaccines have the potential to reduce the burden of respiratory viruses on health systems and pharmacies, as well as offer people more convenient vaccination options that could improve compliance and provide stronger protection from seasonal illnesses,\" Moderna CEO Stephane Bancel said in a statement.In addition to the consumer convenience factor, healthcare providers, retailers and pharmacies may find the combined shot is \"just easier to administer - one shot and you're done,\" Moderna Chief Financial Officer Jamey Mock told MarketWatch. \"And hopefully it reduces the overall cost for them, because it should save time.\"The trial results bode well for other combination shots in Moderna's pipeline, Mock said, by helping to address a couple of questions that were hanging over the experimental vaccines. One concern was whether both antigens in a combination shot could be made to stimulate an immune response at the same time, given that they could potentially interfere with each other. \"Clearly, we were able to do that,\" Mock said.The second concern was whether packing two vaccines into one shot could lead to safety or tolerability issues, Mock said. \"We don't see that\" in the Phase 3 trial results, he said. Side effects of the combination shot included injection-site pain, fatigue, muscle pain and headache, Moderna said, but those issues generally appeared consistent with the stand-alone vaccines currently on the market.Moderna's combined flu and COVID shot includes components of its experimental seasonal flu vaccine mRNA-1010 and its next-generation COVID vaccine candidate mRNA-1283. Moderna in March released late-stage trial results showing that its next-generation COVID vaccine produced better immune results than its original Spikevax shot.It's not yet clear whether those two components of the combined shot would need individual regulatory approval before mRNA-1083 can be approved, Mock said, adding that Moderna hopes it may be able to launch the combined vaccine sometime next year. The Food and Drug Administration last year gave Moderna's combined COVID and flu vaccine fast-track designation, which is designed to speed up the review of drugs that treat serious conditions and fill an unmet medical need.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957801933,"gmtCreate":1677130005623,"gmtModify":1677132258130,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/5FW.SI\">$ACESIAN PARTNERS LIMITED(5FW.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/5FW.SI\">$ACESIAN PARTNERS LIMITED(5FW.SI)$ </a>","text":"$ACESIAN PARTNERS LIMITED(5FW.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957801933","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":204936082325656,"gmtCreate":1691042760903,"gmtModify":1691044335811,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$ </a>","text":"$YZJ Fin Hldg(YF8.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/204936082325656","isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954343201,"gmtCreate":1676031385804,"gmtModify":1676033889299,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P9D.SI\">$CIVMEC LIMITED(P9D.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/P9D.SI\">$CIVMEC LIMITED(P9D.SI)$ </a>","text":"$CIVMEC LIMITED(P9D.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9954343201","isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":326722133528704,"gmtCreate":1720799510622,"gmtModify":1720799513422,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOUN\">$SoundHound AI Inc(SOUN)$</a> ","listText":"<a href=\"https://ttm.financial/S/SOUN\">$SoundHound AI Inc(SOUN)$</a> ","text":"$SoundHound AI Inc(SOUN)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/326722133528704","isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":286273579040928,"gmtCreate":1710925827030,"gmtModify":1710925830427,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/Q0X.SI\">$Ley Choon(Q0X.SI)$</a> ","listText":"<a href=\"https://ttm.financial/S/Q0X.SI\">$Ley Choon(Q0X.SI)$</a> ","text":"$Ley Choon(Q0X.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/286273579040928","isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":273607305072704,"gmtCreate":1707836589600,"gmtModify":1707836594637,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/P52.SI\">$PanUnited(P52.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/P52.SI\">$PanUnited(P52.SI)$ </a>","text":"$PanUnited(P52.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/273607305072704","isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":269740220919984,"gmtCreate":1706863495868,"gmtModify":1706863499641,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","text":"$CapLand Ascott T(HMN.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/269740220919984","isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":263701046235320,"gmtCreate":1705415979945,"gmtModify":1705415983384,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","text":"$Alset International Ltd(40V.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263701046235320","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":263229678129152,"gmtCreate":1705299217413,"gmtModify":1705299220322,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/HMN.SI\">$CapLand Ascott T(HMN.SI)$ </a>","text":"$CapLand Ascott T(HMN.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263229678129152","isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":211227475693680,"gmtCreate":1692594088904,"gmtModify":1692594091145,"author":{"id":"3557888867112544","authorId":"3557888867112544","authorIdStr":"3557888867112544","name":"Desmondsg","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":7,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3557888867112544"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","listText":"<a href=\"https://ttm.financial/S/40V.SI\">$Alset International Ltd(40V.SI)$ </a>","text":"$Alset International Ltd(40V.SI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/211227475693680","isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
